Hydrocele Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

A hydrocele is an abnormal collection of serous fluid within the tunica vaginalis — the double-layered peritoneal membrane that surrounds the testis and the lower portion of the epididymis. Clinically it presents as a smooth, non-tender, fluctuant scrotal swelling that transilluminates brilliantly when a light source is applied — a key distinguishing feature from solid testicular masses.

Hydroceles are broadly categorised into two types. A congenital hydrocele results from failure of the processus vaginalis (a peritoneal outpouching that accompanies testicular descent into the scrotum during fetal development) to obliterate after birth. When the processus remains patent, peritoneal fluid communicates freely with the tunica, producing a communicating hydrocele that characteristically varies in size during the day — larger when the child is upright and active, smaller in the morning after overnight recumbency. The majority close spontaneously by 12–18 months of age.

An acquired hydrocele develops in adults as a secondary reactive response to an underlying condition — inflammation, infection, injury, or tumour — or as a primary idiopathic process common in middle-aged and elderly men. Unlike the congenital variant, acquired hydroceles are non-communicating and do not change size with posture.

Diagnosis is confirmed clinically and by scrotal ultrasound, which is essential before any surgical intervention to exclude underlying testicular malignancy, which can present with a secondary reactive hydrocele in up to 10% of cases. Tumour markers (AFP, beta-hCG, LDH) should be checked in any adult with a new unilateral hydrocele associated with a firm testicular mass on ultrasound.

Hydrocele treatment addresses several distinct clinical presentations:

• Congenital communicating hydrocele: Present from birth due to a patent processus vaginalis. Managed conservatively for the first 18–24 months; surgical high ligation of the processus vaginalis is performed via an inguinal approach if the hydrocele persists beyond this time or enlarges.
• Primary (idiopathic) acquired hydrocele: The most common presentation in adult men; no identifiable underlying cause. Treatment is elective based on symptoms and patient preference.
• Secondary (reactive) hydrocele: Develops in response to ipsilateral epididymo-orchitis, testicular torsion (after detorsion), or trauma. Typically resolves once the underlying cause is treated, but may persist and require drainage.
• Hydrocele associated with testicular tumour: A secondary hydrocele overlying a testicular mass is managed at the time of radical inguinal orchidectomy — the hydrocele is not drained separately beforehand, as this risks tumour seeding along the scrotal lymphatic drainage pathway.
• Filarial hydrocele: Caused by lymphatic obstruction from Wuchereria bancrofti infection (lymphatic filariasis). Endemic in tropical Africa, South Asia, and Pacific regions. Definitive treatment requires surgical hydrocelectomy; anti-filarial pharmacotherapy (diethylcarbamazine, albendazole) treats the parasitic infection but does not resolve established hydroceles.
• Haematocele: Blood within the tunica vaginalis following scrotal trauma or epididymal surgery. Typically requires surgical drainage and evacuation.

Not all hydroceles require active treatment. Management is guided by size, symptoms, rate of change, underlying aetiology, and patient preference.

Indications for intervention include:

• Large, tense hydrocele causing scrotal discomfort, heaviness, a dragging sensation, or restriction of daily activities
• Congenital communicating hydrocele persisting beyond 18–24 months of age, or increasing in size after 12 months
• Any hydrocele where scrotal ultrasound is technically limited or cannot confidently exclude underlying testicular pathology
• Rapid enlargement of a previously small hydrocele (raises concern for secondary cause)
• Patient preference for definitive treatment over ongoing watchful waiting
• Cosmetic or psychosocial concern in symptomatic adults

Pre-operative evaluation: All patients should undergo bilateral scrotal ultrasound to characterise the hydrocele, assess testicular echogenicity and vascularity, and exclude testicular malignancy. Blood tests (FBC, coagulation screen) and fitness for anaesthesia are assessed. Patients with known bleeding disorders require haematology review and pre-operative factor replacement.

Contraindications to surgical repair include active scrotal skin infection (cellulitis, fournier gangrene — must be treated first), uncorrectable coagulopathy, and patients with significant cardiorespiratory comorbidity making general or spinal anaesthesia high-risk. In these patients, aspiration with or without sclerotherapy under local anaesthesia may be preferred.

In paediatric cases, the inguinal approach is strongly preferred over a scrotal approach to avoid inadvertent injury to the vas deferens and testicular blood supply during exploration of the processus vaginalis.

Treatment options range from simple outpatient aspiration to formal surgical hydrocelectomy, depending on patient fitness, hydrocele characteristics, and the presence of underlying pathology.

Open Hydrocelectomy (Definitive Surgical Treatment)

Open surgery via a scrotal incision remains the gold standard, with long-term recurrence rates below 5%. Three principal techniques are used:

• Jaboulay procedure (eversion technique): The most widely performed approach. The hydrocele sac is opened, the fluid drained, the sac edges everted (turned inside-out), and sutured behind the epididymis and posterior testis using absorbable sutures (Vicryl 2-0 or 3-0). Excess sac tissue is excised if the wall is thickened. Suitable for most primary hydroceles of any size.
• Lord's plication technique: Rather than excising or everting the sac, the wall is gathered into pleats and sutured circumferentially around the testis without opening the sac (or with minimal drainage). Less tissue disruption, reduced risk of haematoma, and faster recovery — particularly favoured for thin-walled sacs in elderly patients or those with one functioning testis.
• Eversion with partial excision (Winkelmann technique): Larger or more trabeculated sacs with thick walls may require partial excision of the excess wall before eversion and suture closure. Provides good long-term results with minimal sac remnant.

In paediatric cases with a patent processus vaginalis, surgery is performed through an inguinal incision. The processus vaginalis is isolated and ligated at the internal inguinal ring under direct vision or with laparoscopic assistance. The distal sac is then drained rather than excised to minimise vas deferens and vascular injury.

Aspiration with or without Sclerotherapy

Needle aspiration alone drains the hydrocele fluid under local anaesthesia in outpatients. It provides immediate relief but carries a 50–75% recurrence rate within 6–12 months and is therefore a temporising measure only.

Aspiration with sclerotherapy follows fluid aspiration with injection of a sclerosant agent — tetracycline, phenol 2.5%, sodium tetradecyl sulphate, or polidocanol — into the tunica cavity to obliterate the sac. Success rates of 50–80% have been reported with single or repeated treatments, but long-term outcomes remain inferior to open surgery. Post-procedural discomfort and risk of chemical epididymo-orchitis limit this technique primarily to patients who are poor surgical candidates due to age or medical comorbidity.

Hydrocele treatment, when appropriately indicated, delivers reliable symptomatic and functional benefits:

• Resolution of scrotal swelling and discomfort: Open hydrocelectomy achieves complete resolution of the fluid collection in over 95% of patients, with immediate post-operative relief of dragging and heaviness.
• Low recurrence rate: The recurrence rate after open hydrocelectomy using the Jaboulay or Lord technique is below 5%, in contrast to 50–75% recurrence after aspiration alone.
• Day-case procedure with rapid recovery: Most hydrocelectomies are performed as day surgery under general or spinal anaesthesia with discharge the same day. Return to sedentary work is typically possible within 1–2 weeks.
• Exclusion of underlying pathology: Surgery provides a definitive opportunity to inspect the testis directly, confirm the absence of tumour or other pathology, and submit the excised sac wall for histology if clinically indicated (excluding rare tunica mesothelioma).
• Improved quality of life: Patient-reported satisfaction after hydrocelectomy is high. Cosmetic improvement and relief of anxiety about scrotal swelling are consistently cited benefits alongside physical symptom resolution.
• Preservation of fertility: When performed carefully with attention to the vas deferens and epididymal blood supply — particularly in paediatric inguinal repair — hydrocelectomy does not adversely affect testicular function or fertility in the long term.

Open hydrocelectomy is a low-risk procedure in experienced hands, but patients should be counselled about the following potential complications:

• Haematoma formation: The most common early complication, occurring in 2–5% of cases. The scrotum's rich vascularity predisposes to post-operative bleeding. Small haematomas resolve spontaneously with scrotal support and ice. Larger haematomas may require surgical evacuation under general anaesthesia.
• Wound infection: Superficial wound infections occur in 1–3% of cases and typically respond to oral antibiotics. Deep scrotal infections are rare but may require formal surgical drainage.
• Recurrence: Below 5% after open hydrocelectomy; 50–75% after aspiration alone; 20–50% after aspiration with sclerotherapy — depending on sclerosant agent and number of treatments.
• Chronic scrotal pain: Approximately 2–5% of patients report persistent post-operative scrotal discomfort or aching. This may be related to nerve entrapment in suture lines or reactive epididymitis, and is managed with analgesics, nerve blocks, or rarely revision surgery.
• Injury to vas deferens or epididymal blood supply: This rare but critical complication (<1%) can impair ipsilateral testicular function and is of greatest concern in paediatric inguinal repairs. Surgeons with paediatric urological training and appropriate magnification equipment minimise this risk substantially.
• Lymphocele: A reactive lymphatic fluid collection may develop along the spermatic cord or in the scrotum post-operatively. Most are asymptomatic and resolve spontaneously over weeks to months; rarely require aspiration.
• Chemical epididymo-orchitis: A specific complication of sclerotherapy — the sclerosant agent may irritate the epididymis and testis, causing pain, swelling, and rarely abscess formation. Pre-procedural aspiration of all fluid minimises this risk.

Recovery after hydrocelectomy is generally straightforward. The following post-operative guidance applies to standard open scrotal repair in adults:

Immediate care (first 48–72 hours):

• Firm scrotal support (support brief or dressing) worn continuously for the first 48 hours to minimise haematoma risk
• Ice packs applied to the scrotum for 20 minutes every 2–4 hours reduces swelling and discomfort
• Analgesia: paracetamol 1g four times daily combined with ibuprofen 400mg three times daily (with food) for 5–7 days provides adequate pain control for most patients
• Rest with scrotal elevation when lying down — placing a small rolled towel under the scrotum reduces oedema accumulation

Activity restrictions:

• Sexual abstinence for 4 weeks post-operatively
• Avoid heavy lifting (above 5 kg), straining, and vigorous exercise for 3–4 weeks
• Return to sedentary office work: typically 1–2 weeks
• Return to manual or physical work: 3–4 weeks, or when comfortable
• Return to sport: 4–6 weeks, with surgeon clearance

Follow-up appointments:

• Wound review at 7–14 days post-operatively (absorbable sutures do not require removal)
• If scrotal swelling persists beyond 6–8 weeks, scrotal ultrasound should be performed to exclude haematoma, recurrence, or lymphocele
• Any sign of wound infection (increasing redness, warmth, purulent discharge, fever) should prompt urgent surgical review

Paediatric patients and their parents should receive written information about symptoms of recurrence and testicular torsion, which remains a lifelong risk.

Hydrocelectomy is a straightforward elective procedure with predictable cost structure. Costs vary significantly by country, healthcare setting, and anaesthetic approach.

Approximate procedure costs (USD):

• Open hydrocelectomy — United States: USD 3,000–10,000 total (surgeon, anaesthesia, facility), depending on insurance coverage and day-case versus inpatient admission
• Open hydrocelectomy — India (private hospitals): USD 500–2,000 total, including pre-operative ultrasound and histology
• Open hydrocelectomy — Thailand / Malaysia: USD 1,500–4,000 at accredited private hospitals
• Aspiration with sclerotherapy: USD 300–1,000 as an outpatient procedure; cost advantage may be offset by higher retreatment rates
• Pre-operative scrotal ultrasound: USD 150–400 in the United States; USD 30–80 in India and South/Southeast Asia

Key cost-influencing factors:

• Public versus private healthcare provision (NHS in the UK covers hydrocelectomy on clinical indication at no direct cost)
• General anaesthesia versus spinal or local anaesthesia (the latter reduces anaesthesia fees significantly)
• Paediatric versus adult surgery (paediatric urological subspecialty adds cost)
• Inpatient overnight stay versus day surgery
• Need for histological examination of the excised sac
• Geographic location and surgeon experience level

International patients travelling to India or Southeast Asia for elective hydrocelectomy can expect 60–80% cost savings compared to equivalent procedures in the United States or Western Europe, with no compromise in surgical quality at accredited JCI- or NABH-certified hospitals.

Not all hydroceles require surgical intervention. The appropriate management depends on symptoms, size, rate of growth, and patient fitness.

Watchful waiting (active surveillance): The first-line approach for asymptomatic or minimally symptomatic primary hydroceles in adults, and for all congenital hydroceles in children under 18 months. Annual or biennial review with scrotal ultrasound is appropriate. Approximately 75–80% of congenital hydroceles resolve spontaneously in the first year of life.

Needle aspiration alone: Suitable as a one-time temporising measure in men who are reluctant to undergo surgery or who need rapid symptom relief (e.g., before a long flight or important event). The recurrence rate of 50–75% within 6–12 months makes this a poor long-term strategy unless surgery is definitively contraindicated.

Aspiration plus sclerotherapy: Preferred over aspiration alone for patients who are medically unfit for surgery. Multiple treatment cycles may be required. Success rates of 50–80% have been reported. Contraindicated in patients with suspected secondary hydrocele (possible testicular tumour) as drainage risks staging inaccuracy.

Treatment of the underlying cause: Secondary reactive hydroceles (from epididymo-orchitis or torsion) may resolve spontaneously when the primary pathology is adequately treated. A period of 3–6 months of observation is reasonable before considering surgery for a post-infectious hydrocele.

Laparoscopic closure of patent processus vaginalis: In children requiring bilateral exploration (bilateral clinical hydrocele, or unilateral hydrocele with contralateral undescended testis), laparoscopic assessment via the ipsilateral inguinal incision allows simultaneous inspection and closure of the contralateral processus vaginalis if patent, avoiding a second operation.